DYN Dyne Therapeutics, Inc.
Nasdaq · SEC CIK 1818794 · EDGAR
- Bought, last 12 months
- $274.8K 7 purchases by 1 insiders
- Sold, last 12 months
- $168.62M 38 sales by 6 insiders
- Filings on record
- 301 since 2021-07-13, latest 2026-09-08 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rhodes Jason P | Dir | — | $129.10M |
| Kersten Dirk | Dir | — | $38.57M |
| Cox John | CEO, Pres, Dir | — | $443.7K |
| Posner Brian S | Dir | $274.8K | — |
| Kerr Douglas | Chief Medical Off | — | $233.1K |
| Lucera Erick | CFO | — | $228.7K |
| Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| Lubner David Charles | Dir | — | — |
Transactions 289
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-16 | 2023-11-15 | DYN | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +93.7K | 178.1K | +111% | $0 |
| D | 2023-11-16 | 2023-11-15 | DYN | Brumm Joshua T | See Remarks, Dir | A - Grant | $0.00 | +358.9K | 592.6K | +154% | $0 |
| D | 2023-11-16 | 2023-11-15 | DYN | HIGH SUSANNA GATTI | COO | A - Grant | $0.00 | +94.9K | 189.5K | +100% | $0 |
| 2023-11-02 | 2023-11-02 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $7.40 | -9,939 | 94.6K | -10% | -$73.5K | |
| 2023-09-20 | 2023-09-18 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $9.41 | -2,672 | 104.5K | -2% | -$25.1K | |
| 2023-09-20 | 2023-09-18 | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $9.41 | -12.0K | 233.7K | -5% | -$113.2K | |
| 2023-09-20 | 2023-09-18 | DYN | McNeill Jonathan | Chief Business Off | S - Sale | $9.41 | -1,261 | 60.6K | -2% | -$11.9K | |
| 2023-09-20 | 2023-09-18 | DYN | Scalzo Richard William | See Remarks | S - Sale | $9.41 | -1,290 | 40.8K | -3% | -$12.1K | |
| 2023-09-20 | 2023-09-18 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $9.41 | -1,436 | 84.3K | -2% | -$13.5K | |
| 2023-09-13 | 2023-09-12 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $10.41 | -1,707 | 89.2K | -2% | -$17.8K | |
| 2023-09-13 | 2023-09-12 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $10.41 | -1,484 | 85.8K | -2% | -$15.4K | |
| 2023-09-13 | 2023-09-12 | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $10.41 | -7,672 | 245.7K | -3% | -$79.9K | |
| 2023-09-13 | 2023-09-12 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $10.41 | -1,635 | 107.2K | -2% | -$17.0K | |
| 2023-09-13 | 2023-09-12 | DYN | Scalzo Richard William | See Remarks | S - Sale | $10.41 | -1,397 | 42.1K | -3% | -$14.5K | |
| 2023-09-13 | 2023-09-12 | DYN | McNeill Jonathan | Chief Business Off | S - Sale | $10.41 | -1,266 | 61.9K | -2% | -$13.2K | |
| DM | 2023-06-15 | 2023-06-13+ | DYN | Scalzo Richard William | See Remarks | S - Sale+OE | $12.71 | -51.4K | 43.5K | -54% | -$653.2K |
| D | 2023-06-15 | 2023-06-13 | DYN | Scalzo Richard William | See Remarks | M - OptEx | $1.03 | +40.0K | 93.5K | +75% | +$41.2K |
| 2023-06-14 | 2023-06-13 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $12.43 | -1,698 | 91.0K | -2% | -$21.1K | |
| 2023-06-14 | 2023-06-13 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $12.43 | -1,475 | 87.3K | -2% | -$18.3K | |
| 2023-06-14 | 2023-06-13 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $12.43 | -1,625 | 108.9K | -1% | -$20.2K | |
| M | 2023-06-14 | 2023-06-12+ | DYN | McNeill Jonathan | See Remarks | S - Sale | $12.68 | -2,259 | 64.4K | -3% | -$28.6K |
| DM | 2023-06-12 | 2023-06-08 | DYN | Brumm Joshua T | See Remarks, Dir | G - Gift | $0.00 | -21.8K | 302.5K | -7% | $0 |
| DM | 2023-06-12 | 2023-06-08+ | DYN | Brumm Joshua T | See Remarks, Dir | M - OptEx | $1.03 | +278.0K | 441.1K | +170% | +$286.4K |
| DM | 2023-06-12 | 2023-06-08+ | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale+OE | $12.90 | -325.3K | 269.8K | -55% | -$4.20M |
| 2023-03-15 | 2023-03-14 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $13.33 | -1,416 | 88.7K | -2% | -$18.9K | |
| 2023-03-15 | 2023-03-14 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $13.33 | -7,441 | 92.7K | -7% | -$99.2K | |
| 2023-03-15 | 2023-03-14 | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $13.33 | -7,318 | 322.5K | -2% | -$97.5K | |
| 2023-03-15 | 2023-03-14 | DYN | Scalzo Richard William | See Remarks | S - Sale | $13.33 | -1,311 | 54.9K | -2% | -$17.5K | |
| 2023-03-15 | 2023-03-14 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $13.33 | -1,559 | 110.5K | -1% | -$20.8K | |
| M | 2023-03-15 | 2023-03-13+ | DYN | McNeill Jonathan | See Remarks | S - Sale | $13.18 | -2,209 | 65.4K | -3% | -$29.1K |
| D | 2023-01-23 | 2023-01-18 | DYN | McNeill Jonathan | See Remarks | M - OptEx | $0.73 | +10.0K | 77.6K | +15% | +$7,300 |
| D | 2023-01-23 | 2023-01-18 | DYN | McNeill Jonathan | See Remarks | S - Sale+OE | $14.03 | -10.0K | 67.6K | -13% | -$140.3K |
| 2023-01-11 | 2023-01-09 | DYN | McNeill Jonathan | See Remarks | S - Sale | $11.57 | -30.1K | 67.6K | -31% | -$348.8K | |
| 2022-12-14 | 2022-12-12 | DYN | Atlas Venture Opportunity Fund II, L.P. | 10% | P - Purchase | $10.70 | +934.6K | 934.6K | New | +$10.00M | |
| I | 2022-12-14 | 2022-12-12 | DYN | Rhodes Jason P | Dir | P - Purchase | $10.70 | +934.6K | 934.6K | New | +$10.00M |
| D | 2022-12-13 | 2022-12-09 | DYN | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +40.0K | 90.8K | +79% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $10.87 | -680 | 90.1K | -0.7% | -$7,392 |
| D | 2022-12-13 | 2022-12-12 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $10.87 | -628 | 100.1K | -0.6% | -$6,826 |
| D | 2022-12-13 | 2022-12-09 | DYN | Farwell Wildon | Chief Medical Off | A - Grant | $0.00 | +36.0K | 100.7K | +56% | $0 |
| D | 2022-12-13 | 2022-12-09 | DYN | McNeill Jonathan | See Remarks | A - Grant | $0.00 | +40.0K | 98.2K | +69% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | McNeill Jonathan | See Remarks | S - Sale | $10.87 | -472 | 97.8K | -0.5% | -$5,131 |
| D | 2022-12-13 | 2022-12-12 | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $10.87 | -3,322 | 329.8K | -1.0% | -$36.1K |
| D | 2022-12-13 | 2022-12-09 | DYN | Brumm Joshua T | See Remarks, Dir | A - Grant | $0.00 | +144.0K | 333.1K | +76% | $0 |
| D | 2022-12-13 | 2022-12-09 | DYN | HIGH SUSANNA GATTI | COO | A - Grant | $0.00 | +44.0K | 112.8K | +64% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $10.87 | -751 | 112.0K | -0.7% | -$8,163 |
| D | 2022-12-13 | 2022-12-12 | DYN | Scalzo Richard William | See Remarks | S - Sale | $10.87 | -312 | 56.2K | -0.6% | -$3,391 |
| D | 2022-12-13 | 2022-12-09 | DYN | Scalzo Richard William | See Remarks | A - Grant | $0.00 | +31.0K | 56.5K | +122% | $0 |
| DM | 2022-10-11 | 2022-10-10 | DYN | Brumm Joshua T | See Remarks, Dir | G - Gift | $0.00 | -15.5K | 191.6K | -7% | $0 |
| DM | 2022-10-11 | 2022-10-07+ | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale+OE | $12.52 | -210.0K | 204.6K | -51% | -$2.63M |
| DM | 2022-10-11 | 2022-10-07+ | DYN | Brumm Joshua T | See Remarks, Dir | M - OptEx | $1.03 | +210.0K | 218.8K | +2,380% | +$216.3K |
| 2022-09-21 | 2022-09-20 | DYN | McNeill Jonathan | See Remarks | D - Sale to Iss | $13.70 | -1,246 | 58.2K | -2% | -$17.1K | |
| 2022-09-21 | 2022-09-20 | DYN | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $13.70 | -2,629 | 68.8K | -4% | -$36.0K | |
| 2022-09-21 | 2022-09-20 | DYN | Brumm Joshua T | See Remarks, Dir | D - Sale to Iss | $13.70 | -11.8K | 204.6K | -5% | -$162.2K | |
| 2022-09-21 | 2022-09-20 | DYN | Scalzo Richard William | See Remarks | D - Sale to Iss | $13.70 | -840 | 25.5K | -3% | -$11.5K | |
| 2022-09-21 | 2022-09-20 | DYN | Beskrovnaya Oxana | CSO | D - Sale to Iss | $13.70 | -1,413 | 50.8K | -3% | -$19.4K | |
| 2022-09-15 | 2022-09-15 | DYN | Beskrovnaya Oxana | CSO | D - Sale to Iss | $14.05 | -712 | 52.2K | -1% | -$10.0K | |
| 2022-09-15 | 2022-09-15 | DYN | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $14.05 | -786 | 71.4K | -1% | -$11.0K | |
| 2022-09-15 | 2022-09-15 | DYN | Farwell Wildon | Chief Medical Off | D - Sale to Iss | $14.05 | -658 | 64.7K | -1% | -$9,245 | |
| 2022-09-15 | 2022-09-15 | DYN | Scalzo Richard William | See Remarks | D - Sale to Iss | $14.05 | -326 | 26.3K | -1% | -$4,580 | |
| 2022-09-15 | 2022-09-15 | DYN | McNeill Jonathan | See Remarks | D - Sale to Iss | $14.05 | -494 | 59.5K | -0.8% | -$6,941 | |
| 2022-09-15 | 2022-09-15 | DYN | Brumm Joshua T | See Remarks, Dir | D - Sale to Iss | $14.05 | -3,480 | 216.5K | -2% | -$48.9K | |
| D | 2022-07-06 | 2022-07-06 | DYN | Brumm Joshua T | See Remarks, Dir | D - Sale to Iss | $8.24 | -11.0K | 219.9K | -5% | -$90.3K |
| D | 2022-07-06 | 2022-07-05 | DYN | Brumm Joshua T | See Remarks, Dir | A - Grant | $0.00 | +24.1K | 230.9K | +12% | $0 |
| 2022-06-15 | 2022-06-14 | DYN | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $4.95 | -802 | 72.2K | -1% | -$3,970 | |
| 2022-06-15 | 2022-06-14 | DYN | Brumm Joshua T | See Remarks, Dir | D - Sale to Iss | $4.95 | -3,540 | 206.8K | -2% | -$17.5K | |
| 2022-06-15 | 2022-06-14 | DYN | McNeill Jonathan | See Remarks | D - Sale to Iss | $4.95 | -504 | 60.0K | -0.8% | -$2,495 | |
| 2022-06-15 | 2022-06-14 | DYN | Farwell Wildon | Chief Medical Off | D - Sale to Iss | $4.95 | -668 | 65.4K | -1% | -$3,307 | |
| 2022-06-15 | 2022-06-14 | DYN | Beskrovnaya Oxana | CSO | D - Sale to Iss | $4.95 | -726 | 53.0K | -1% | -$3,594 | |
| 2022-06-15 | 2022-06-14 | DYN | Scalzo Richard William | See Remarks | D - Sale to Iss | $4.95 | -333 | 26.7K | -1% | -$1,648 | |
| 2022-03-14 | 2022-03-11 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $8.73 | -765 | 73.0K | -1% | -$6,678 | |
| 2022-03-14 | 2022-03-11 | DYN | Scalzo Richard William | See Remarks | S - Sale | $8.73 | -308 | 27.0K | -1% | -$2,689 | |
| 2022-03-14 | 2022-03-11 | DYN | Beskrovnaya Oxana | CSO | S - Sale | $8.73 | -693 | 53.7K | -1% | -$6,050 | |
| 2022-03-14 | 2022-03-11 | DYN | McNeill Jonathan | See Remarks | S - Sale | $8.73 | -481 | 60.5K | -0.8% | -$4,199 | |
| 2022-03-14 | 2022-03-11 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $8.73 | -640 | 66.0K | -1.0% | -$5,587 | |
| 2022-03-14 | 2022-03-11 | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $8.73 | -3,384 | 210.3K | -2% | -$29.5K | |
| 2022-03-03 | 2022-03-02 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $8.56 | -5,617 | 66.7K | -8% | -$48.1K | |
| D | 2021-12-14 | 2021-12-10 | DYN | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +36.5K | 54.4K | +205% | $0 |
| D | 2021-12-14 | 2021-12-10 | DYN | McNeill Jonathan | See Remarks | A - Grant | $0.00 | +25.3K | 60.9K | +71% | $0 |
| D | 2021-12-14 | 2021-12-10 | DYN | COO | A - Grant | $0.00 | +40.3K | 73.8K | +121% | $0 | |
| D | 2021-12-14 | 2021-12-10 | DYN | Farwell Wildon | Chief Medical Off | A - Grant | $0.00 | +22.3K | 72.3K | +45% | $0 |
| D | 2021-12-14 | 2021-12-10 | DYN | Scalzo Richard William | See Remarks | A - Grant | $0.00 | +16.7K | 27.3K | +157% | $0 |
| D | 2021-12-14 | 2021-12-10 | DYN | Brumm Joshua T | See Remarks, Dir | A - Grant | $0.00 | +118.2K | 213.7K | +124% | $0 |
| 2021-10-04 | 2021-10-01 | DYN | Brumm Joshua T | See Remarks, Dir | G - Gift | $0.00 | -3,500 | 95.5K | -4% | $0 | |
| 2021-09-24 | 2021-09-23 | DYN | HIGH SUSANNA GATTI | COO | S - Sale | $17.22 | -2,451 | 33.5K | -7% | -$42.2K | |
| M | 2021-09-22 | 2021-09-20+ | DYN | Beskrovnaya Oxana | CSO | S - Sale | $15.90 | -1,444 | 17.8K | -7% | -$23.0K |
| M | 2021-09-22 | 2021-09-20+ | DYN | McNeill Jonathan | See Remarks | S - Sale | $15.90 | -1,274 | 36.4K | -3% | -$20.3K |
| M | 2021-09-22 | 2021-09-20+ | DYN | Brumm Joshua T | See Remarks, Dir | S - Sale | $15.90 | -8,009 | 99.0K | -7% | -$127.3K |
| M | 2021-09-22 | 2021-09-20+ | DYN | Scalzo Richard William | See Remarks | S - Sale | $15.90 | -859 | 11.1K | -7% | -$13.7K |
| 2021-07-15 | 2021-07-13 | DYN | Atlas Venture Fund XI, L.P. | 10% | J - Other | $0.00 | -814.0K | 7.33M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations